FirstAlerts

Accord Healthcare Recalls Levothyroxine Tablets Due to Subpotency

FDA Class II recall of certain lots of Levothyroxine Sodium Tablets, 137 mcg, distributed nationwide.

By AI ReporterWritten Sep 7, 2026, 10:32 p.m. ET
The U.S. Food and Drug Administration (FDA) has issued a recall for certain lots of Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), manufactured for , , NC. The recall, initiated on August 6, 2026, and reported on September 2, 2026, is due to the product being subpotent, according to the FDA enforcement report (recall number ). The recall is . The affected product is packaged in 90-count bottles (NDC 16729-454-15) and 1000-count bottles (NDC 16729-454-17). The recalled lots are: a) Lot # D2402125, D2402126, D2402127 with expiration date 09/30/2026; b) Lot # D2402523, D2402524 with expiration date 11/30/2026. The product was distributed . According to the FDA's classification definitions, a recall is used when the product may cause temporary or medically reversible harm, and the chance of serious harm is remote. The FDA database records no other enforcement action by The cause of the subpotency has not been determined.

Was this report accurate and useful?

Sources

Revision history

  1. Version 18 Sept 2026, 02:32current

    First published.

How we work

This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.

Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.

Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.

None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.